Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Rank in Stocks #107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Share Price
$41.14
Last synced: 2026-09-21
Market Cap
$182.76B
Change (1 day)
-7.78%
Change (1 year)
-32.24%
Country
DK
Trade Novo Nordisk A/S (NOVO-B)

Category

Operating Margin for Novo Nordisk A/S (NOVO-B)
Operating Margin as of September 2026 TTM: 43.13%
According to Novo Nordisk A/S latest financial reports and stock price the company's current Operating Margin (TTM) is 43.13%. At the end of 2024 the company had an Operating Margin of 44.19%.
Operating Margin history for Novo Nordisk A/S from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 43.13% 4.18%
2025 41.40% -6.31%
2024 44.19% 0.07%
2023 44.16% 4.45%
2022 42.28% 1.51%
2021 41.65% -2.32%
2020 42.64% -0.86%
2019 43.01% 1.80%
2018 42.25% -3.63%
2017 43.84% 1.18%
2016 43.33% -5.41%
2015 45.81% 17.95%
2014 38.84% 3.08%
2013 37.68% -0.24%
2012 37.77% 12.01%
2011 33.72% 8.49%
2010 31.08% 6.29%
2009 29.24% 7.66%
2008 27.16% 27.03%
2007 21.38% -9.14%
2006 23.53% -1.75%
2005 23.95% -0.42%
2004 24.05% -0.04%
2003 24.06% 1.31%
2002 23.75% 0.64%
2001 23.60% 15.74%
2000 20.39% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
43.92% -98.98%
US
26.81% -99.38%
US
29.32% -99.32%
US
26.59% -99.38%
CH
16.65% -99.61%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.